American Vietnamese Biotech (HSTC:AMV) Accounts Receivable : ₫0.00 Mil (As of . 20)

View and export this data going back to 2009. Start your Free Trial

What is American Vietnamese Biotech Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. American Vietnamese Biotech's accounts receivables for the quarter that ended in . 20 was ₫0.00 Mil.

Accounts receivable can be measured by Days Sales Outstanding.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. American Vietnamese Biotech's Net-Net Working Capital per share for the quarter that ended in . 20 was ₫N/A.

American Vietnamese Biotech Accounts Receivable Historical Data

The historical data trend for American Vietnamese Biotech's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Vietnamese Biotech Accounts Receivable Chart

American Vietnamese Biotech Annual Data

Trend

Accounts Receivable

American Vietnamese Biotech Quarterly Data

Accounts Receivable

American Vietnamese Biotech Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

American Vietnamese Biotech Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

American Vietnamese Biotech's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=		/		*	91
=

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), American Vietnamese Biotech's accounts receivable are only considered to be worth 75% of book value:

American Vietnamese Biotech's Net-Net Working Capital Per Share for the quarter that ended in . 20 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(	+	0.75 *	+	0.5 *	-	N/A
-		-	)	/	0
=	N/A

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

American Vietnamese Biotech Accounts Receivable Related Terms

Thank you for viewing the detailed overview of American Vietnamese Biotech's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

American Vietnamese Biotech (HSTC:AMV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Vietnamese Biotech Inc (HSTC:AMV) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

N/A

Address

20 Road 13, Block DC Song Da, Thu Duc Ward, Ho Chi Minh, VNM

Website

http://www.amvibiotech.com

American Vietnamese Biotech Incorporation is engaged in trading in pharmaceuticals, purchasing and selling medical equipment, medical testing instruments and chemicals; producing and trading vaccines and medical biological products; real estate business and financial investment.